Physician profile
Corwin Nozari
NPI 1366031403
$727.73
in general payments reported to CMS, 2019-2025
10 companies · $167 in 2025
The $167 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $111 · 2023: $315 · 2024: $135 · 2025: $167.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $617.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $617.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $145.79 | 2024-2025 | Euflexxa |
| Abbvie INC. | $138.18 | 2022-2024 | |
| Neurocrine Biosciences, INC. | $134.09 | 2023 | Ingrezza |
| Vertex Pharmaceuticals Incorporated | $97.08 | 2024-2025 | |
| Amgen INC. | $81.23 | 2022-2023 | Repatha, Otezla, Evenity |
| Lilly USA, LLC | $43.01 | 2022 | |
| Exact Sciences Corporation | $31.78 | 2023 | Cologuard Collection Kit |
| Smith+Nephew, INC. | $26.39 | 2025 | Allevyn Heel 10.5cm X 13.5cm Ctn 5 |
| Paratek Pharmaceuticals, INC. | $15.64 | 2023 | Nuzyra |
| Novo Nordisk INC | $14.54 | 2023 | Ozempic, Rybelsus |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Corwin Nozari listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.